P3 Health Partners Inc. (PIII)
Automate Your Wheel Strategy on PIII
With Tiblio's Option Bot, you can configure your own wheel strategy including PIII - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PIII
- Rev/Share 455.5804
- Book/Share 37.1408
- PB 0.3221
- Debt/Equity 2.8917
- CurrentRatio 0.3776
- ROIC -0.9294
- MktCap 20425563.0
- FreeCF/Share -37.9031
- PFCF -0.1653
- PE -0.148
- Debt/Assets 0.2333
- DivYield 0
- ROE -1.2907
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Published: June 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Read More
Bears are Losing Control Over P3 Health Partners (PIII), Here's Why It's a 'Buy' Now
Published: June 12, 2025 by: Zacks Investment Research
Sentiment: Negative
After losing some value lately, a hammer chart pattern has been formed for P3 Health Partners (PIII), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Read More
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Read More
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Published: June 03, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a distinguished law firm with over 125 years of history, announces it is investigating claims on behalf of investors of P3 Health Partners, Inc. (NASDAQ: PIII) (“P3” or the “Company”). (NASDAQ: PIII)
Read More
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)
Published: May 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The heavy selling pressure might have exhausted for P3 Health Partners (PIII) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
Published: May 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Read More
P3 Health Partners Inc. (PIII) Q1 2025 Earnings Call Transcript
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral
P3 Health Partners Inc. (NASDAQ:PIII ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Ryan Halstead - Managing Director, Gilmartin Group LLC, IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medical Officer Conference Call Participants Josh Raskin - Nephron Research Ryan Langston - TD Cowen Operator Good day, and welcome to the P3 Health Partners First Quarter 2025 Earnings Conference Call. All participants will be in listen-only-mode.
Read More
P3 Health Partners Inc. (PIII) Reports Q1 Loss, Tops Revenue Estimates
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Negative
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.28 per share versus the Zacks Consensus Estimate of a loss of $5. This compares to loss of $8 per share a year ago.
Read More
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Published: March 05, 2025 by: Zacks Investment Research
Sentiment: Positive
P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.
Read More
About P3 Health Partners Inc. (PIII)
- IPO Date 2021-04-06
- Website https://p3hp.org
- Industry Medical - Care Facilities
- CEO Dr. Aric Coffman M.D.
- Employees 360